Bioverativ Inc. 4
4 · Bioverativ Inc. · Filed Mar 2, 2017
Insider Transaction Report
Form 4
Bioverativ Inc.BIVV
Celona Lucia
EVP, HR & Corp Commun. Officer
Transactions
- Tax Payment
Common Stock
2017-02-28$43.42/sh−301$13,069→ 20,613 total - Tax Payment
Common Stock
2017-02-28$43.42/sh−790$34,302→ 19,049 total - Tax Payment
Common Stock
2017-02-28$43.42/sh−650$28,223→ 21,917 total - Award
Common Stock
2017-02-28+22,567→ 22,567 total - Tax Payment
Common Stock
2017-02-28$49.56/sh−235$11,647→ 21,682 total - Tax Payment
Common Stock
2017-02-28$47.76/sh−768$36,680→ 20,914 total - Tax Payment
Common Stock
2017-02-28$49.56/sh−182$9,020→ 20,431 total - Tax Payment
Common Stock
2017-02-28$47.76/sh−592$28,274→ 19,839 total
Footnotes (2)
- [F1]Includes restricted stock units granted by Bioverativ Inc. ("Bioverativ") to the reporting person as a result of the conversion of existing Biogen Inc. ("Biogen") cash-settled performance units, market stock units and restricted stock units held by the reporting person prior to the Spin-Off of Bioverativ from Biogen on February 1, 2017, as set forth in an employee matters agreement entered into between Bioverativ and Biogen in connection with the Spin-Off. Restricted stock units that are unvested continue to vest on the dates of the original Biogen awards.
- [F2]Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units.